多动脉与单动脉冠状动脉旁路移植:结果的性别相关差异
Justin Ren1,2, Andrea Bowyer1,3,4, David H Tian1,5
1Department of Surgery, University of Melbourne, 300 Grattan St, Parkville, Melbourne 3052, Australia.
European heart journal
|May 31, 2024
概括
多重动脉移植改善了冠状动脉旁路移植的男性和女性的长期存活率. 在大多数患者群体中观察到这种生存益处,这表明它在心脏手术中的有效性.
科学领域:
- 心血管外科心血管外科
- 手术结果研究研究.
- 临床流行病学 临床流行病学
背景情况:
- 在冠状动脉旁路移植 (CABG) 中,多重动脉移植 (MAG) 与单个动脉移植 (SAG) 的性别特异性结果存在不确定性.
- 根据移植策略和患者性别评估长期生存差异对于优化CABG程序至关重要.
研究的目的:
- 在CABG中比较接受MAG和SAG的患者的长期存活率.
- 与SAG相比,对MAG的生存益处的潜在性别相关差异进行调查.
主要方法:
- 澳大利亚和新西兰心胸外科数据库协会与国家死亡指数 (2001-2020) 相关的回顾性分析.
- 用反向概率加权的考克斯比例危险模型用于性别分层的生存比较.
- 评估的主要结局是全因死亡率.
主要成果:
- 该研究分析了54,275名成年患者,其中19.7%是女性,54.7%接受了MAG.
- 与SAG相比,MAG与男性 (aHR 0.82) 和女性 (aHR 0.83) 的死亡率明显降低.
- 对MAG的生存益处在各个子组中一致,除了左主冠状动脉疾病的女性患者.
结论:
- 与单个动脉移植相比,多重动脉再血管化证明了较好的长期存活率.
- 马格的生存优势适用于接受CABG的女性和男性患者.
- 在广泛的CABG患者中,MAG是提高长期结果的有益策略.
相关概念视频
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...